2021年10月5日简报:欧洲药管局批准所有成人打辉瑞加强针;卡塔尔将中国新冠疫苗列入认可疫苗清单;英国进一步简化入境政策

2021-10-05 MedSci整理 MedSci整理

截至北京时间2021年10月5日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23606万例,新增307,395例,达到236,062,47

截至北京时间2021年10月5日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过23606万例,新增307,395例,达到236,062,476例。累计死亡病例482.0万例,达到4,820,705例。新增死亡为4,313例。康复为213,065,964例,重症和危重症病人达到86,410例;全球新冠确诊病例超过100万例的国家达35个,110个国家病例超10万例。昨日报道:2021年10月4日简报:数据模型预测明年春天将恢复正常生活;口罩与疫苗将是未来的标配;新冠疫苗加强针方案逐步成熟

中东多国接连投产中国新冠疫苗

中国与中东国家抗疫合作再传捷报。继埃及阿联酋之后,阿尔及利亚日前宣布,与中国科兴公司合作生产新冠疫苗的项目正式投产,成为中东地区第三个与中国合作生产疫苗的国家。

阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。

欧洲药管局批准所有成人打辉瑞加强针

欧洲药品管理局(EMA)10月4日宣布,建议为18岁及以上成年人接种第三针辉瑞新冠疫苗;而免疫系统严重削弱人士,可在接种第二针的28天后,补种第三针辉瑞或莫德纳新冠疫苗。

要打新冠疫苗的不止人类。芬兰近日宣布,将为该国养殖场200万只水貂接种一款实验性新冠疫苗。这让芬兰成为全球首个为动物接种新冠疫苗的国家。

欧洲药品管理局还宣布,免疫系统严重削弱的群体,可在接种第二针的28天后,补种第三针辉瑞或莫德纳疫苗。声明称,对接受过器官移植手术病人的研究显示,第三针加强针可以有效提高生成抗体的能力。

印度卫生部:25%以上成年人完成两剂新冠疫苗接种

印度卫生部长4日表示,印度70%以上的适龄人口接种了第一剂新冠肺炎疫苗。截至10月4日,印度累计接种新冠疫苗剂量突破了9.1亿剂,25%以上的成年人接种了两剂疫苗,现在各地还有5600万剂的疫苗库存。

巴西里约市超7万名老年人未按期接种“加强针”疫苗

巴西媒体当地时间10月3日报道,该国第二大城市里约热内卢约在1个月前开始为60岁及以上老年人接种新冠疫苗第三剂“加强针”。此前,该年龄段群体已完成了单剂或两剂新冠疫苗的注射。

但根据里约热内卢约市疫苗接种监测系统的统计,在80岁及以上已完成第二剂疫苗接种的老年人中,仍有至少72762人没有到政府指定的接种点注射“加强针”疫苗,这一数值占该年龄段群体总数的27%。

里约市卫生局局长丹尼尔·索兰兹(Daniel Soranz)表示,出行困难是导致老年群体无法到指定站点进行疫苗接种的主要障碍之一,尤其是80岁及以上的老年人。目前,里约市政府恢复了对老年人群体提供上门接种疫苗的服务,符合条件人员可在市政府网站进行“加强针”注射的申请。

但该市卫生局也指出,与接种首剂新冠疫苗时相比,申请在家注射“加强针”疫苗的老年人数量明显下降。据悉,今年年初,申请上门注射第一剂疫苗服务的老年人数量为14611人,与此相比,目前申请在家接种“加强针”疫苗的老年人数量仅为3321人。

卡塔尔将中国新冠疫苗列入认可疫苗清单

根据卡塔尔公共卫生部10月4日公布的最新消息,该国将中国科兴公司生产的新冠疫苗列入了“有条件认可的疫苗清单”。新规将从10月6日14时起生效。

今年7月,卡塔尔已将中国国药集团生产的新冠疫苗列入“有条件认可的疫苗清单”。按照规定,接种过两剂“有条件认可”疫苗的人员,在入境卡塔尔之后需接受新冠抗体检测,如果结果为阳性,则免除隔离。

从7月起,卡塔尔将全球所有国家和地区按照疫情严重程度分为“绿色”“黄色”和“红色”国家,中国为“绿色”国家。从“绿色”国家入境的人员无须提前进行核酸检测

阿根廷启动3岁至11岁儿童的新冠疫苗接种工作

当地时间10月2日起,阿根廷启动3岁至11岁儿童的新冠疫苗登记接种工作。阿根廷儿科医师学会发表声明,支持政府的决定,认为这能有效地降低新冠病毒社区感染的风险,并能保证学生能够重返课堂。

当日,阿根廷卫生部公布,该国新增新冠肺炎确诊病例886例,累计确诊5259352例;新增死亡病例14例,累计死亡115239例;累计治愈5121667例,现有病例22446例,其中重症病例1070例。

中国向几内亚比绍援助第二批新冠疫苗

当地时间10月4日,中国政府援助几内亚比绍政府第二批新冠疫苗交接仪式在首都比绍抗击新冠肺炎疫情高级专员办公室隆重举行。几内亚比绍抗疫高级专员席尔瓦代表恩巴洛总统、几内亚比绍政府和人民感谢中国政府和人民再次提供的疫苗援助。

德国城镇协会反对取消学校内的口罩令

当地时间10月4日,德国城镇协会警告不要过早取消学校内的口罩令。协会主席兰德斯博格表示,学生是一个高风险群体,大多数青少年还不能接种疫苗,而他们每天必须在相对较小的封闭空间里学习几个小时。根据德国疾控机构罗伯特·科赫研究所的数据,近期感染新冠病毒的情况在学龄前儿童和19岁以下的青少年群体中尤为严重。

英国10月4日起进一步简化入境政策

英国政府当地时间10月4日宣布,当天凌晨4时起,英国开始实施新的入境规定,现有的“红绿灯系统”规则将进行大幅度的简化。前往英国的国际旅行规则已从红色、琥珀色、绿色的“红绿灯系统”改为单一的红色国家名单,并简化来自世界其他地区游客的旅行措施。未列入红色名单的国家和地区的旅行规则,取决于游客的疫苗接种状态。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1058380, encodeId=2af9105838096, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:39:23 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260513, encodeId=dfae126051377, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339413, encodeId=db271339413bc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603951, encodeId=331916039510f, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057902, encodeId=134b105e902b9, content=阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01cd5545296, createdName=ms4000000713143940, createdTime=Tue Oct 05 15:09:45 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057867, encodeId=e318105e867de, content=加强针, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 05 11:27:38 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057859, encodeId=7654105e85940, content=才承认中国疫苗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c2b1620925, createdName=泽9867, createdTime=Tue Oct 05 11:12:57 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057767, encodeId=b042105e76780, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Oct 05 08:43:50 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057744, encodeId=4a5d105e74422, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 05 07:22:52 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2021-10-07 老龙一点

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1058380, encodeId=2af9105838096, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:39:23 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260513, encodeId=dfae126051377, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339413, encodeId=db271339413bc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603951, encodeId=331916039510f, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057902, encodeId=134b105e902b9, content=阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01cd5545296, createdName=ms4000000713143940, createdTime=Tue Oct 05 15:09:45 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057867, encodeId=e318105e867de, content=加强针, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 05 11:27:38 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057859, encodeId=7654105e85940, content=才承认中国疫苗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c2b1620925, createdName=泽9867, createdTime=Tue Oct 05 11:12:57 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057767, encodeId=b042105e76780, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Oct 05 08:43:50 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057744, encodeId=4a5d105e74422, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 05 07:22:52 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2021-10-06 bioon3
  3. [GetPortalCommentsPageByObjectIdResponse(id=1058380, encodeId=2af9105838096, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:39:23 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260513, encodeId=dfae126051377, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339413, encodeId=db271339413bc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603951, encodeId=331916039510f, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057902, encodeId=134b105e902b9, content=阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01cd5545296, createdName=ms4000000713143940, createdTime=Tue Oct 05 15:09:45 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057867, encodeId=e318105e867de, content=加强针, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 05 11:27:38 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057859, encodeId=7654105e85940, content=才承认中国疫苗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c2b1620925, createdName=泽9867, createdTime=Tue Oct 05 11:12:57 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057767, encodeId=b042105e76780, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Oct 05 08:43:50 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057744, encodeId=4a5d105e74422, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 05 07:22:52 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1058380, encodeId=2af9105838096, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:39:23 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260513, encodeId=dfae126051377, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339413, encodeId=db271339413bc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603951, encodeId=331916039510f, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057902, encodeId=134b105e902b9, content=阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01cd5545296, createdName=ms4000000713143940, createdTime=Tue Oct 05 15:09:45 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057867, encodeId=e318105e867de, content=加强针, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 05 11:27:38 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057859, encodeId=7654105e85940, content=才承认中国疫苗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c2b1620925, createdName=泽9867, createdTime=Tue Oct 05 11:12:57 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057767, encodeId=b042105e76780, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Oct 05 08:43:50 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057744, encodeId=4a5d105e74422, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 05 07:22:52 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1058380, encodeId=2af9105838096, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:39:23 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260513, encodeId=dfae126051377, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339413, encodeId=db271339413bc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603951, encodeId=331916039510f, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057902, encodeId=134b105e902b9, content=阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01cd5545296, createdName=ms4000000713143940, createdTime=Tue Oct 05 15:09:45 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057867, encodeId=e318105e867de, content=加强针, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 05 11:27:38 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057859, encodeId=7654105e85940, content=才承认中国疫苗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c2b1620925, createdName=泽9867, createdTime=Tue Oct 05 11:12:57 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057767, encodeId=b042105e76780, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Oct 05 08:43:50 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057744, encodeId=4a5d105e74422, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 05 07:22:52 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2021-10-05 ms4000000713143940

    阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1058380, encodeId=2af9105838096, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:39:23 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260513, encodeId=dfae126051377, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339413, encodeId=db271339413bc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603951, encodeId=331916039510f, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057902, encodeId=134b105e902b9, content=阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01cd5545296, createdName=ms4000000713143940, createdTime=Tue Oct 05 15:09:45 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057867, encodeId=e318105e867de, content=加强针, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 05 11:27:38 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057859, encodeId=7654105e85940, content=才承认中国疫苗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c2b1620925, createdName=泽9867, createdTime=Tue Oct 05 11:12:57 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057767, encodeId=b042105e76780, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Oct 05 08:43:50 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057744, encodeId=4a5d105e74422, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 05 07:22:52 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2021-10-05 SR~young海东

    加强针

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1058380, encodeId=2af9105838096, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:39:23 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260513, encodeId=dfae126051377, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339413, encodeId=db271339413bc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603951, encodeId=331916039510f, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057902, encodeId=134b105e902b9, content=阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01cd5545296, createdName=ms4000000713143940, createdTime=Tue Oct 05 15:09:45 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057867, encodeId=e318105e867de, content=加强针, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 05 11:27:38 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057859, encodeId=7654105e85940, content=才承认中国疫苗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c2b1620925, createdName=泽9867, createdTime=Tue Oct 05 11:12:57 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057767, encodeId=b042105e76780, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Oct 05 08:43:50 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057744, encodeId=4a5d105e74422, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 05 07:22:52 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2021-10-05 泽9867

    才承认中国疫苗?

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1058380, encodeId=2af9105838096, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:39:23 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260513, encodeId=dfae126051377, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339413, encodeId=db271339413bc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603951, encodeId=331916039510f, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057902, encodeId=134b105e902b9, content=阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01cd5545296, createdName=ms4000000713143940, createdTime=Tue Oct 05 15:09:45 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057867, encodeId=e318105e867de, content=加强针, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 05 11:27:38 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057859, encodeId=7654105e85940, content=才承认中国疫苗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c2b1620925, createdName=泽9867, createdTime=Tue Oct 05 11:12:57 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057767, encodeId=b042105e76780, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Oct 05 08:43:50 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057744, encodeId=4a5d105e74422, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 05 07:22:52 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2021-10-05 ms5000001266883663

    学习#学习#

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1058380, encodeId=2af9105838096, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc4d2208236, createdName=老龙一点, createdTime=Thu Oct 07 14:39:23 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260513, encodeId=dfae126051377, content=<a href='/topic/show?id=1ed65e476b8' target=_blank style='color:#2F92EE;'>#政策#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57476, encryptionId=1ed65e476b8, topicName=政策)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=322359, createdName=bioon3, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339413, encodeId=db271339413bc, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1603951, encodeId=331916039510f, content=<a href='/topic/show?id=f06536499c1' target=_blank style='color:#2F92EE;'>#卡塔尔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36499, encryptionId=f06536499c1, topicName=卡塔尔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d37d19121627, createdName=旅苦化文_214, createdTime=Wed Oct 06 22:13:25 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057902, encodeId=134b105e902b9, content=阿尔及利亚赛达尔医药集团和科兴公司合作生产新冠疫苗的项目9月29日正式投产。根据规划,该项目在今年10月即可生产100万剂疫苗,明年年产量有望达9600万剂,可以完全满足阿尔及利亚国民接种需求并向非洲其他国家出口。 , beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=01cd5545296, createdName=ms4000000713143940, createdTime=Tue Oct 05 15:09:45 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057867, encodeId=e318105e867de, content=加强针, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Tue Oct 05 11:27:38 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057859, encodeId=7654105e85940, content=才承认中国疫苗?, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c2b1620925, createdName=泽9867, createdTime=Tue Oct 05 11:12:57 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057767, encodeId=b042105e76780, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Tue Oct 05 08:43:50 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057744, encodeId=4a5d105e74422, content=了解一下, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Tue Oct 05 07:22:52 CST 2021, time=2021-10-05, status=1, ipAttribution=)]
    2021-10-05 学医无涯

    了解一下

    0

相关资讯

张文宏凌晨发长文解读南京疫情,关键在于后续1-2周的监测

近期南京疫情跨省传播,成为大家最关心的话题之一。

2021年10月1日简报:新冠疫情致欧美多国人口预期寿命缩短;新冠疫情将进入新常态,年底可能会上市多种新冠病毒口服治疗药物;仅15个非洲国家完成了10%的新冠疫苗接种阶段目标

截至北京时间2021年10月1日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23451万例,新增474,237例,达到234,514,13

新冠战争已彻底改变,先不要急着说“与病毒长期共存”!

近期美国CDC文件显示Delta突变株具有超强的传染性!即使对已完成疫苗接种的人来说,当感染了Delta变异株时,与没有接种疫苗的感染者相比,体内仍会产生相同数量的病毒,且传染力相差无几。

新冠变异毒株“德尔塔”持续扩散,南京何以几近封城?

江苏正遭遇过去一年来最严重的本土疫情。

2021年8月7日简报:全国多地实行全员核酸检测,筛选感染人群;美国2008年就成功合成新型冠状病毒;Lambda毒株可能是delta毒株后的新王者

截至北京时间2021年8月7日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过20235万例,新增689,707例,达到202,352,487

此轮南京疫情涉及2省4地,42人感染,你如何看?

7月22日0-24时,江苏新增本土确诊病例12例和7例本土无症状感染者。其中,南京当日新增本土确诊病例12例(其中5例轻型,7例普通型),新增无症状感染者6例,多数为禄口国际机场工作人员。此外,江苏省